Literature DB >> 3117468

Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

P L Lollini1, C De Giovanni, B Del Re, G Nicoletti, G Prodi, P Nanni.   

Abstract

The relationship between major histocompatibility complex (MHC) antigens and metastasis was investigated on B16 melanoma variants. B16 cell lines express low amounts of murine MHC (H-2) antigens. A high expression can be induced in line B16-A by in vitro treatment with immune interferon (IFN-gamma) or by in vivo transplant in allogeneic mice. The increase of H-2 antigens correlated with an enhancement of lung colonization in young syngeneic mice. The higher metastatic capacity of B16-A cells with induced high levels of H-2 antigens was observed also in adult mice and in young mice pretreated with cyclophosphamide. These results were confirmed investigating the behaviour of a mutant B16 clone (B78H1) which was selectively resistant to the H-2-inducing action of IFN-gamma: lung colonization ability was not increased by IFN pretreatment. The study of variants derived from individual B16-A lung colonies revealed a wide range of H-2 levels. Variants with a low expression had a low colonization ability; one out of two variants with a high H-2 expression also was poorly colonizing. IFN-gamma-mediated H-2 expression appeared to act as an enhancer, rather than a determinant of B16 metastatic capacity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117468     DOI: 10.1007/bf00120723

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  26 in total

1.  Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.

Authors:  K Taniguchi; K Kärre; G Klein
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

2.  Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens.

Authors:  P G Natali; M Viora; M R Nicotra; P Giacomini; A Bigotti; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

3.  Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones.

Authors:  L H Graf; P Kaplan; S Silagi
Journal:  Somat Cell Mol Genet       Date:  1984-03

4.  Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.

Authors:  I J Fidler; D M Gersten; M B Budmen
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

5.  Gamma-interferon (IFN-gamma) produced during effector and target interactions renders target cells less susceptible to NK-cell-mediated lysis.

Authors:  A Grönberg; R Kiessling; G Masucci; L A Guevara; E Eriksson; G Klein
Journal:  Int J Cancer       Date:  1983-11-15       Impact factor: 7.396

Review 6.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

7.  Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection.

Authors:  R Wallich; N Bulbuc; G J Hämmerling; S Katzav; S Segal; M Feldman
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

8.  Histocompatibility antigens on murine tumors.

Authors:  R S Goodenow; J M Vogel; R L Linsk
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

9.  Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice.

Authors:  J Nishimura; K Mitsui; Y Tanaka; R Yamamoto; Y Suhara; H Ishitsuka
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects.

Authors:  M Blackmore; S Thompson; G A Turner
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

Review 3.  Radiation enhancement of metastasis: a review.

Authors:  C F von Essen
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

4.  Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma.

Authors:  P L Lollini; C De Giovanni; G Nicoletti; A Bontadini; P L Tazzari; L Landuzzi; K Scotlandi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

5.  Equus caballus major histocompatibility complex class I is an entry receptor for equine herpesvirus type 1.

Authors:  Brian M Kurtz; Lauren B Singletary; Sean D Kelly; Arthur R Frampton
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  Selection for enhanced adhesion to microvessel endothelial cells or resistance to interferon-gamma modulates the metastatic potential of murine RAW117 large-cell lymphoma cells.

Authors:  R A LaBiche; R J Tressler; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

7.  Suppression by interferon-gamma of tumor cell-induced increase in mesothelial permeability.

Authors:  A Uchiyama; H Kitsuki; H Shimura; M Torisu
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

8.  In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.

Authors:  H I Levitsky; A Lazenby; R J Hayashi; D M Pardoll
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

9.  Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered.

Authors:  Indra N Dahmke; Christina Backes; Jeannette Rudzitis-Auth; Matthias W Laschke; Petra Leidinger; Michael D Menger; Eckart Meese; Ulrich Mahlknecht
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

Review 10.  The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway.

Authors:  Laura Martin-Hijano; Bruno Sainz
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.